Cost-effectiveness of point-of-care testing for dehydration in the pediatric ED

Rachel E Whitney1, Karen Santucci1, Allen Hsiao1

  • 1Department of Pediatrics, Section of Emergency Medicine, Yale University School of Medicine, New Haven, CT 06510.

Insights

Point-of-care (POC) electrolyte testing in pediatric emergency departments for acute gastroenteritis (AGE) significantly reduces costs for both payers and providers compared to traditional serum testing. This cost-effective approach aids in managing dehydration in children.

Area of Science:

  • Pediatric Emergency Medicine
  • Health Economics
  • Clinical Diagnostics

Background:

  • Acute gastroenteritis (AGE) and dehydration are common reasons for pediatric emergency department (PED) visits.
  • Point-of-care (POC) testing is increasingly used for dehydration assessment, but its cost-effectiveness in the PED is not well-established.
  • Traditional serum chemistry testing is the standard but may be less efficient.

Purpose of the Study:

  • To conduct a cost-effectiveness analysis of POC electrolyte testing versus traditional serum chemistry testing for children with AGE in the PED.
  • To evaluate cost savings from both payer and provider perspectives.

Main Methods:

  • A cost-effectiveness analysis utilizing data from a randomized control trial involving children with AGE.
  • A decision analysis model was developed to calculate cost savings.
  • Parameters included testing costs, admission rates, admission costs, and length of stay.
  • Sensitivity analyses were performed to ensure model stability.

Main Results:

  • POC testing yielded a cost saving of $303.30 per patient for payers compared to traditional serum testing.
  • POC testing provided mean savings of $36.32 per patient for providers ($8.29-$64.35).
  • Sensitivity analyses confirmed the model's stability and consistent cost savings.

Conclusions:

  • POC electrolyte testing in children with moderate dehydration due to AGE leads to significant cost savings for both payers and providers.
  • This supports the adoption of POC testing as a cost-effective diagnostic strategy in the PED setting.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
455
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
698
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
426